Table II.
Tissue and indicator, statistical test | Carcinoma tissue XPO4 | Adjacent tissue XPO4 | Carcinoma tissue TGFβ1 | Adjacent tissue TGFβ1 | Carcinoma tissue ANGPTL4 | Adjacent tissue ANGPTL4 | Carcinoma tissue elF5A2 | Adjacent tissue elF5A2 | TNM |
---|---|---|---|---|---|---|---|---|---|
Carcinoma tissue XPO4 | |||||||||
Correlation | 1 | 0.304b | 0.038 | 0.126a | 0.506b | 0.199b | 0.478b | 0.194b | 0.052 |
Sig. (2-tailed) | - | 0.000 | 0.562 | 0.047 | 0.000 | 0.002 | 0.000 | 0.002 | 0.415 |
n | 261 | 250 | 239 | 251 | 258 | 249 | 257 | 245 | 249 |
Adjacent tissue XPO4 | |||||||||
Correlation | 0.304b | 1 | 0.029 | 0.142a | 0.118 | 0.224b | 0.106 | 0.215b | 0.042 |
Sig. (2-tailed) | 0.000 | - | 0.663 | 0.023 | 0.062 | 0.000 | 0.096 | 0.001 | 0.512 |
n | 250 | 257 | 234 | 256 | 249 | 254 | 248 | 252 | 247 |
Carcinoma tissue TGFβ1 | |||||||||
Correlation | 0.038 | 0.029 | 1 | 0.467b | 0.104 | 0.172b | 0.047 | 0.065 | 0.402b |
Sig. (2-tailed) | 0.562 | 0.663 | - | 0.000 | 0.109 | 0.008 | 0.468 | 0.329 | 0.000 |
n | 239 | 234 | 241 | 234 | 238 | 233 | 237 | 230 | 230 |
Adjacent tissue TGFβ1 | |||||||||
Correlation | 0.126a | 0.142a | 0.467b | 1 | 0.085 | 0.228b | 0.066 | 0.103 | 0.299b |
Sig. (2-tailed) | 0.047 | 0.023 | 0.000 | - | 0.181 | 0.000 | 0.299 | 0.104 | 0.000 |
n | 251 | 256 | 234 | 258 | 250 | 254 | 249 | 251 | 247 |
Carcinoma tissue ANGPTL4 | |||||||||
Correlation | 0.506b | 0.118 | 0.104 | 0.085 | 1 | 0.282b | 0.469b | 0.245b | 0.125a |
Sig. (2-tailed) | 0.000 | 0.062 | 0.109 | 0.181 | - | 0.000 | 0.000 | 0.000 | 0.049 |
n | 258 | 249 | 238 | 250 | 260 | 248 | 259 | 244 | 248 |
Adjacent tissue ANGPTL4 | |||||||||
Correlation | 0.199b | 0.224b | 0.172b | 0.228b | 0.282b | 1 | 0.239b | 0.477b | 0.142a |
Sig. (2-tailed) | 0.002 | 0.000 | 0.008 | 0.000 | 0.000 | - | 0.000 | 0.000 | 0.025 |
n | 249 | 254 | 233 | 254 | 248 | 256 | 247 | 252 | 247 |
Carcinoma tissue elF5A2 | |||||||||
Correlation | 0.478b | 0.106 | 0.047 | 0.066 | 0.469b | 0.239b | 1 | 0.371b | 0.050 |
Sig. (2-tailed) | 0.000 | 0.096 | 0.468 | 0.299 | 0.000 | 0.000 | - | 0.000 | 0.437 |
n | 257 | 248 | 237 | 249 | 259 | 247 | 259 | 244 | 248 |
Adjacent tissue elF5A2 | |||||||||
Correlation | 0.194b | 0.215b | 0.065 | 0.103 | 0.245b | 0.477b | 0.371b | 1 | 0.127a |
Sig. (2-tailed) | 0.002 | 0.001 | 0.329 | 0.104 | 0.000 | 0.000 | 0.000 | 0.047 | |
n | 245 | 252 | 230 | 251 | 244 | 252 | 244 | 252 | 244 |
TNM | |||||||||
Correlation | 0.052 | 0.042 | 0.402b | 0.299b | 0.125a | 0.142a | 0.050 | 0.127a | 1 |
Sig. (2-tailed) | 0.415 | 0.512 | 0.000 | 0.000 | 0.049 | 0.025 | 0.437 | 0.047 | - |
n | 249 | 247 | 230 | 247 | 248 | 247 | 248 | 244 | 256 |
Correlation is considered to be statistically significant at the 0.05 level (2-tailed).
Correlation is considered to be statistically significant at the 0.01 level (2-tailed). The correlation in expression of XPO4 between the cancerous and paracancerous liver tissue was positive (CC=0.304, P<0.001). Expression of XPO4 in the cancerous liver tissue was positively correlated with expression of TGFβ1 (CC=0.199, P=0.047) in paracancerous liver tissue, expression of ANGPTL4 (CC=0.506, P=0.000) in cancerous liver tissue, expression of ANGPTL4 (CC=0.199, P=0.002) in paracancerous liver tissue and expression of elF5A2 (CC=0.194, P=0.002) in paracancerous liver tissue, respectively. These results suggest that expression of these four indicators is internally connected and that there is modulation between each of them. TNM, TNM classification of malignant tumors.